The evaluation of rapid methicillin-resistant Staphylococcus aureus (MRSA) screening
Completed
- Conditions
- Methicillin-resistant Staphylococcus aureus (MRSA) colonisation and infectionInfections and InfestationsStaphylococcus aureus infection
- Registration Number
- ISRCTN84432505
- Lead Sponsor
- Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 12000
Inclusion Criteria
1. Patients greater than 18 years of age, either sex
2. Admitted to seven surgical wards at Heart of England NHS Foundation Trust
Exclusion Criteria
Patients less than 18 years of age
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. MRSA transmission rates<br>2. MRSA infection rates<br>3. Antibiotic prescribing levels<br>4. MRSA related morbidity<br>5. Test replicability, reliability, sensitivity/specificity, predictive positive value (PPV), negative predictive value (NPV), laboratory turn-around time
- Secondary Outcome Measures
Name Time Method 1. Cost of hospital episode for all patients<br>2. Post-discharge primary/community care costs and any subsequent admissions for MRSA positives<br>3. Length of stay/intensive care unit (ITU) episodes for all patients<br>4. Recovery/rehabilitation period for MRSA positives